Elizabeth Anne Eady

Tudor Investment Corp. (TIC) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Stamford, Connecticut. The firm was founded in 1980 by Paul T. Jones, II. TIC provides discretionary investment advisory services to various hedge funds, private equity funds and managed accounts. Investors in these funds generally include high-net worth individuals and related entities, sovereign entities, pension funds, non-financial corporates, financial institutions, endowments and foundations, fund-of-fund vehicles and proprietary capital from current and former personnel.

Reckitt Benckiser Healthcare International Ltd. manufactures healthcare and beauty products. The company develops & markets analgesics, upper respiratory tract and skincare products. It is headquartered in Nottingham, the United Kingdom.

Tudor Capital Europe LLP is an alternative investment manager headquartered in London, UK. The firm was founded in 1995 and is a subsidiary of Tudor Overseas Holdings LLC, which is owned by Tudor Investment Corp. in the US. Tudor Capital Europe manages assets across fixed income, currency, equity and commodity asset classes and related derivative instruments in the global markets for an international clientele.

Adams Healthcare Ltd. manufactures and distributes infection control and dermatology products to hospitals, primary care specialists, and patients. The company was founded on June 19, 2007 and is headquartered in Nechells, the United Kingdom.

Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys.

GlaxoSmithKline Consumer Healthcare manufactures and supplies over the counter drugs. It focuses on oral healthcare, over the counter medicines and nutritional healthcare products. Its brands and products include oral care (Aquafresh) to dermatology (Zovirax), with all kinds of analgesics (Panadol), gastrointestinal remedies (Tums) and smoking-cessation products (Nicoderm). The company is headquartered in Brentford, UK

Perachem Ltd. researches and develops chemicals.

Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom.

Cizzle Biotechnology Ltd. develops therapeutic products for lung cancer. The firm promotes DNA replication and is involved in its organization and control. The company was founded by Dawn Coverley and Justin Ainscough in 2005 and is headquartered in York, the United Kingdom.

KPMG UK Ltd. provides financial services. It offers accounting, audit, tax, and financial advisory services. The company was founded on June 12, 1998 and is headquartered in London, the United Kingdom.

SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada.

Proveca Ltd. develops pharmaceuticals for children and adults through studies dedicated to providing evidence for the specific use of off-patent medicines. The firm develops medicines for children in the fields of cardiology, neurology, and pain management. The company was founded by Simon Peter Bryson and Helen Margaret Shaw in July 2010 and is headquartered in Warrington, the United Kingdom.

NuVision Biotherapies Ltd. commercializes biotherapies for treating ‘front of the eye’ disease and trauma. It offers Omnigen, an ‘off the shelf’, transportable biological matrix that can be used as an effective wound dressing for a range of indications including ocular surface indications. The firm also offers Tereo, a process that gently preserves the tissue such that it is stored in a dry state. The company was founded by Andrew Hopkinson in July 2014 and is headquartered in Nottingham, the United Kingdom.

Neotherix Ltd. is a British company that specializes in soft tissue repair using the body's natural healing abilities. Neotherix is based in York, UK and was founded in 2007 by Mike Raxworthy, who has been the CEO since then. The private company has developed innovative solutions for wound repair using electrospun scaffolds and phototherix™ technology that reduces the need for antibiotics. The company's seton scaffold device™ (ssd) is used to support ongoing active seton drainage and tissue regrowth. The company's ektotherix™ technology uses electrospun fibers for cell attachment and movement into the wound space to successfully heal wounds with minimal scarring.

Veriton Pharma Ltd. engages in the development and manufacture of pharmaceutical products which focuses in the fields of epilepsy, neurology and rare paediatric conditions. It offers Epistatus, paediatric medicine, and inborn errors of metabolism medicine. The company was founded by Graham March in 1997 and is headquartered in Weybridge, the United Kingdom.